Form 4: Jazz Pharma Director Exercises Options, Sells Shares

Jazz Pharmaceuticals plc Director Heather McSharry exercised non-qualified stock options and subsequently sold 3,415 ordinary shares.

Summary

• Heather McSharry, a Director of Jazz Pharmaceuticals plc, engaged in an insider transaction on November 20, 2025.
• McSharry exercised 3,415 non-qualified stock options at an exercise price of $138.08 per share.
• Immediately following the exercise, 3,415 ordinary shares were sold at a price of $177.7823 per share.
• The options were granted on August 11, 2016, and fully vested by August 1, 2017, with an expiration date of August 10, 2026.
• Following these transactions, McSharry directly owns 20,449 ordinary shares and no derivative securities.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction (exercise and sell) which is neutral in sentiment. It indicates the director realized a gain but also reduced direct share ownership, which is common for liquidity or diversification purposes.

Positives

• The director realized a profit from exercising options at $138.08 and selling shares at $177.7823, indicating a gain of $39.7023 per share.

Negatives

• The director's direct beneficial ownership of ordinary shares decreased by 3,415 shares following the sale.

Future Outlook

N/A. This filing reports a past insider transaction and does not contain forward-looking statements or guidance.

Industry Context

N/A. This Form 4 filing details an individual insider transaction and does not provide broader industry context.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine, relatively small insider transaction for liquidity/diversification purposes, not indicative of a change in company fundamentals or strategy.

Key Dates

Keywords

Jazz Pharmaceuticals, JAZZ, Form 4, Insider Transaction, Stock Option Exercise, Share Sale, Director, Equity Transaction